CURE spoke with Dr. William C. Huang about what kind of team…
Month: March 2025
233 posts
First-line Rybrevant Combo Extends Survival in Advanced Lung Cancer
First-line Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in mutated,…
COCOON Trial Regimen Reduces Dermatologic Side Effects in Mutated Lung Cancer
The COCOON trial regimen reduced dermatologic side effects in patients with EGFR-mutant…
FDA Approves New Treatment for PNETs: What You Need to Know
Mar 31, 2025 – By Erin Post The U.S. Food & Drug…
The Positivity Trap of Follicular Lymphoma and Cancer
As a lymphoma survivor, I struggle with the positivity trap — sometimes,…
Patient With Head and Neck Cancer Dosed in Trial of APR-1051
A patient with HPV-positive head and neck squamous cell carcinoma was dosed…
Relacorilant Plus Chemo Meets Primary Goal in Ovarian Cancer Trial
The phase 3 trial showed relacorilant with chemotherapy improved progression-free and overall…
Inside the Mind of a Bile Duct Cancer Survivor
I’ve spent 14 years navigating recovery, mental health challenges and giving back…
Why Early Cancer Detection Is a Game-Changer
Early cancer detection can mean the difference between life and death. Many…
First Patient Dosed in Trial of [212Pb]VMT01 for Metastatic Melanoma
The first patient has been dosed with [212Pb]VMT01 in a phase 1/2a…
What Patients With Kidney Cancer Need to Know From ASCO GU
There were a number of notable developments for patients with kidney cancer…
Research Shines Light on Disparities Across Breast Cancer Care
Dr. Regina Hampton discusses key factors contributing to this disparity, and how…
